(Q54372017)

28 May 2018

title

Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma. (English)

1 reference

28 May 2018

author name string

Hyun Joo Jung

series ordinal

1

1 reference

28 May 2018

Zheng Chen

series ordinal

2

1 reference

28 May 2018

Nami McCarty

series ordinal

3

1 reference

28 May 2018

publication date

1 June 2011

1 reference

28 May 2018

published in

Leukemia & Lymphoma

1 reference

28 May 2018

volume

52

1 reference

28 May 2018

issue

6

1 reference

28 May 2018

page(s)

1066-1079

1 reference

28 May 2018

Overview of non-Hodgkin's lymphoma

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Management of non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Advances in the understanding of mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Prospective isolation of clonogenic mantle cell lymphoma-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Characterization of clonogenic multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Cancer stem cell biology: from leukemia to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

CD133+ cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133- cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Cancer stem cells and chemoradiation resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

In vitro drug resistance in B cell chronic lymphocytic leukemia: a comparison with acute myelocytic and acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

In vitro drug resistance versus chemosensitivity: two sides of different coins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

From the bench to the bedside: ways to improve rituximab efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

The human ATP-binding cassette (ABC) transporter superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Pharmacogenetics of membrane transporters: an update on current approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Lymphoma stem cells: enough evidence to support their existence?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

How I treat mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Mantle cell lymphoma: state-of-the-art management and future perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Cancer stem cells: Models, mechanisms and implications for improved treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Molecular biology of mantle cell lymphoma: from profiling studies to new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Current treatment standards and emerging strategies in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Therapy of mantle cell lymphoma: current standards and future strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Current treatment approaches for mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

DNA damage, neuronal and glial cell death and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

What of apoptosis is important: the decay process or the causative origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Enhanced growth in NS0 cells expressing aminoglycoside phosphotransferase is associated with changes in metabolism, productivity, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Optimizing combination chemotherapy by controlling drug ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Lipid-based nanoparticulate systems for the delivery of anti-cancer drug cocktails: Implications on pharmacokinetics and drug toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

The ABC transporter Abcg2/Bcrp: role in hypoxia mediated survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Low rhodamine 123 retention identifies long-term human hematopoietic stem cells within the Lin-CD34+CD38- population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Targeting breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

Cancer Stem Cells and Radiotherapy: New Insights Into Tumor Radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.562570

10.3109/10428194.2011.562570

21 January 2018

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018